全球聚合物生醫材料市場（按產品、應用和地區分類）

2025 年全球聚合物生醫材料市場規模預計為 670.3 億美元，預計到 2032 年將達到 1,687.6 億美元，2025 年至 2032 年複合年成長率為 14.1%。

數字。 2025年全球市場佔有率聚合物生醫材料各地區市佔率（%）

聚合物生醫材料是用於醫療應用和醫療設備的生物相容性聚合物。由於其生物分解性和生物相容性，它們在組織工程和再生醫學應用中發揮重要作用。聚合物生醫材料包括膠原蛋白和彈性蛋白等天然聚合物，以及Polyglycolic(PGA)、聚乳酸 (PLA) 和聚己內酯 (PCL) 等合成聚合物。這些聚合物可調節的物理化學性質和分解行為使其成為藥物傳輸載體、醫療植入和組織再生支架的有吸引力的候選材料。由於聚合物生物生醫材料在心血管、整形外科、牙科和創傷治療應用中的使用日益增多，全球聚合物生醫材料市場正經歷顯著成長。

市場動態：

全球聚合物生醫材料市場的主要驅動力是慢性病盛行率的上升、老年人口的成長以及醫療植入和組織工程程序的使用增加。根據聯合國預測，到 2050 年，65 歲及以上人口將從 2020 年的 7.03 億增加到 15 億。人口老化預計將推動用於植入、組織支架和其他醫療應用的聚合物生醫材料的需求。此外，具有可調分解特性、加工技術多功能性的新型生物可吸收聚合物的開發以及再生醫學研究的不斷增加也在推動市場成長。然而，嚴格的監管核准流程和高昂的研發成本可能會阻礙市場擴張。然而，新興經濟體醫療保健投資的不斷成長和醫療技術的進步預計將在預測期內創造新的機會。

本研究的主要特點

• 本研究報告對全球聚合物生醫材料市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
• 它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 全球聚合物生醫材料市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球聚合物生醫材料市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過用於分析全球聚合物生醫材料市場的各種策略矩陣來更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
• 主要亮點
• 監管情景
• 近期動態
• PEST分析
• 波特分析
• 合併、收購和合作

4. 全球聚合物生醫材料市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 全球聚合物生醫材料市場（依產品分類），2020-2032

• 聚乳酸（PLA）
• Polyglycolic（PGA）
• 聚氨酯
• 聚四氟乙烯 (PTFE) 和膨體聚四氟乙烯 (ePTFE)
• 聚芳醚醚酮（PEEK）
• 氧環己酮聚合體（PDO）
• 其他

6. 全球聚合物生醫材料市場（按應用分類），2020-2032

• 心血管系統
• 生物可吸收支架
• 血管移植物
• 感應器
• 導管導引線
• 植入式心臟心臟去顫器
• 心律調節器
• 其他
• 牙科
• 組織再生材料
• 人工植牙
• 骨移植和骨替代物
• 齒片
• 牙科縫合線
• 其他
• 整形外科
• 關節重建聚合物生物材料
• 組織固定產品
• 生物性骨材
• 關節內粘稠補充療法
• 脊椎生物材料
• 其他
• 整形外科
• 臉部除皺治療
• 軟組織填充劑
• 顱顏外科
• 生物工程皮膚
• 周邊神經修復
• 去細胞真皮基質
• 其他
• 神經病學
• 神經幹細胞的封裝
• 調車系統
• 用於中樞神經系統修復的水凝膠支架
• 皮質神經假體
• 其他

7. 全球聚合物生醫材料市場（按地區分類），2020-2032

• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第8章競爭格局

• 公司簡介
  • Stryker
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc（Invibio Ltd.）
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation

第9章 章節

• 參考
• 調查方法
• 關於出版商

Global Polymeric Biomaterials Market is estimated to be valued at USD 67.03 Bn in 2025 and is expected to reach USD 168.76 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.1% from 2025 to 2032.

Figure. Global Polymeric Biomaterials Market Share (%), By Region 2025

Polymeric biomaterials are polymers that are biocompatible and are used in medical applications and devices. They plays an important role in tissue engineering and regenerative medicine applications due to their biodegradability and biocompatibility properties. Polymeric biomaterials can be natural polymers such as collagen, elastin or synthetic polymers like polyglycolic acid(PGA), polylactic acid (PLA) or polycaprolactone (PCL). These polymers are attractive candidates for drug delivery vehicles, medical implants, and scaffolds for tissue regeneration due to their tunable physicochemical properties and degradation behavior. Global polymeric biomaterials market is growing at a significant rate due to the increasing use of polymeric biomaterials in cardiovascular, orthopedic, dental and wound healing applications.

Market Dynamics:

Global polymeric biomaterials market is primarily driven by the rising prevalence of chronic diseases, growing geriatric population, increasing medical implants and tissue engineering procedures. According to the United Nations, the number of people aged 65 years and above is projected to grow from 703 Mn in 2020 to 1.5 billion by 2050. The increase in ageing population is expected to boost the demand for polymeric biomaterials used in implants, tissue scaffolds and other medical applications. Moreover, development of novel bioabsorbable polymers with tunable degradation properties, versatility in processing techniques and increasing research in regenerative medicine also helps to fuel the market growth. However, stringent regulatory approval process and high costs associated with research and development (R&D) could hamper the market expansion. Nevertheless, growing healthcare investments in emerging nations and ongoing advancements in medical technology are projected to unlock new opportunities over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global polymeric biomaterials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global polymeric biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global polymeric biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polymeric biomaterials market

Detailed Segmentation:

• Global Polymeric Biomaterials Market, By Product
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
  • Polyurethanes
  • Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Polyaryletheretherketone (PEEK)
  • Polydioxanone (PDO)
  • Others
• Global Polymeric Biomaterials Market, By Application
  • Cardiovascular
  • Bioresorbable Stents
  • Vascular Grafts
  • Sensors
  • Guidewires
  • Implantable Cardiac Defibrillators
  • Pacemakers
  • Others
  • Dental
  • Tissue Regeneration Materials
  • Dental Implants
  • Bone Grafts & Substitutes
  • Dental Membranes
  • Dental Sutures
  • Others
  • Orthopedic
  • Joint Replacement Polymeric Biomaterials
  • Tissue Fixation Products
  • Suture Anchors
  • Others
  • Orthobiologics
  • Viscosupplementation
  • Spine Biomaterials
  • Others
  • Plastic Surgery
  • Facial Wrinkle Treatment
  • Soft Tissue Fillers
  • Craniofacial Surgery
  • Sutures
  • Others
  • Bioengineered Skins
  • Peripheral Nerve Repair
  • Acellular Dermal Matrices
  • Others
  • Neurology
  • Neural Stem Cell Encapsulation
  • Shunting Systems
  • Hydrogel Scaffold For CNS Repair
  • Cortical Neural Prosthetics
  • Others
  • Others
• Global Polymeric Biomaterials Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Stryker
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc (Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Polymeric Biomaterials Market, By Product
  • Global Polymeric Biomaterials Market, By Application
  • Global Polymeric Biomaterials Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing orthopedic and dental applications
  • Stringent regulatory environment
  • Emerging markets in Asia Pacific and Latin America
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Polymeric Biomaterials Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Polymeric Biomaterials Market, By Product, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Polylactic Acid (PLA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyglycolic Acid (PGA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyurethanes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polyaryletheretherketone (PEEK)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Polydioxanone (PDO)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Polymeric Biomaterials Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Bioresorbable Stents
• Vascular Grafts
• Sensors
• Guidewires
• Implantable Cardiac Defibrillators
• Pacemakers
• Others
• Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tissue Regeneration Materials
• Dental Implants
• Bone Grafts & Substitutes
• Dental Membranes
• Dental Sutures
• Others
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Joint Replacement Polymeric Biomaterials
• Tissue Fixation Products
  • Suture Anchors
  • Others
• Orthobiologics
• Viscosupplementation
• Spine Biomaterials
• Others
• Plastic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Facial Wrinkle Treatment
• Soft Tissue Fillers
• Craniofacial Surgery
  • Sutures
  • Others
• Bioengineered Skins
• Peripheral Nerve Repair
• Acellular Dermal Matrices
• Others
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neural Stem Cell Encapsulation
• Shunting Systems
• Hydrogel Scaffold For CNS Repair
• Cortical Neural Prosthetics
• Others
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Polymeric Biomaterials Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profile
  • Stryker
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc (Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
• Analyst Views

9. Section

• References
• Research Methodology
• About us